(Q47789825)

English

LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects

scientific article published on 11 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

lysergic acid diethylamide

1 reference

based on heuristic

inferred from title

author name string

Peter Gasser

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

Katharina Kirchner

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

Torsten Passie

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

language of work or name

0 references

publication date

11 November 2014

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

Journal of Psychopharmacology

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

29

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

57-68

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

Hallucinations: synchronisation of thalamocortical gamma oscillations underconstrained by sensory input

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Generic aspects of complexity in brain imaging data and other biological systems

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Mapping the structural core of human cerebral cortex

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

The Role of Neurotrophins in Major Depressive Disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Long Lasting Effects of LSD on Normals

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Acute Adverse Reactions to Lsd in Clinical and Experimental use in the United Kingdom

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Psychopathology and pathophysiology of the self in depression - neuropsychiatric hypothesis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

The pharmacology of lysergic acid diethylamide: a review

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Frontocingulate dysfunction in depression: toward biomarkers of treatment response

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

The neural correlates of consciousness: an analysis of cognitive skill learning

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Response of cluster headache to psilocybin and LSD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Facial emotion processing in major depression: a systematic review of neuroimaging findings

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

A systems model of altered consciousness: integrating natural and drug-induced psychoses

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli

1 reference

https://api.crossref.org/works/10.1177%2F0269881114555249

21 January 2018

Identifiers

10.1177/0269881114555249

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25389218

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47789825&oldid=2171092622"